Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protoporphyrin IX (PpIX)-generated reactive oxygen species (ROS) target a wide range of general cellular components, including lipids, proteins, and nucleic acids, primarily within the mitochondria, lysosomes, and plasma membranes. In photodynamic therapy (PDT), PpIX serves as a photosensitizer that absorbs light energy and transfers it to molecular oxygen, creating highly reactive singlet oxygen (Agostinis et al., 2011). Because these ROS have a very short biological half-life and a limited diffusion radius, the damage is strictly localized to the site of PpIX accumulation (Wachowska et al., 2011). The oxidative modification of membrane lipids, known as lipid peroxidation, and the degradation of vital proteins disrupt cellular integrity and signaling. This multi-targeted oxidative stress triggers cell death through apoptotic, necrotic, or autophagic pathways (Castano et al., 2004). This mechanism is the therapeutic basis for drugs like 5-aminolevulinic acid (5-ALA), which act as prodrugs for PpIX. It is widely used in the treatment of actinic keratosis and various malignant tumors. Unlike targeted therapies that hit a single receptor, this approach causes widespread damage to the cellular machinery within the illuminated area. Consequently, it is effective against a variety of cell types but requires precise light delivery to avoid off-target effects in healthy tissue.
Type II photochemical reaction where Protoporphyrin IX (PpIX) absorbs light energy and transfers it to molecular oxygen, generating singlet oxygen and other reactive oxygen species (ROS) that cause non-specific oxidative damage to cellular structures (Agostinis et al., 2011).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular components exposed to Protoporphyrin IX-generated reactive oxygen species.